Clinical Trial Update: Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Oncaspar (pegaspargase)
• asparaginase (E. coli-derived) (asparaginase)

Snippet

Sponsor: medac GmbH | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED